The efficacy and safety of dose-escalating methods in patients with benign prostate hyperplasiaafter initial doxazosin 4mg: Doxaosin 8mg, combined therapy with doxazosin 4mg and tamsulosin 0.2mg or finasteride 5mg

被引:0
|
作者
Cho, I. [1 ]
Kim, J. [1 ]
Lee, K. [1 ]
机构
[1] Inje Univ, Ilsanpaik Hosp, Koyang, South Korea
关键词
D O I
10.1016/S1569-9056(07)60348-0
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:110 / 110
页数:1
相关论文
共 7 条
  • [1] COMPARISON OF THE EFFICACY AND SAFETY OF TOLTERODINE SR 2MG AND 4MG COMBINED WITH DOXAZOSIN IN MEN WITH LOWER URINARY TRACT SYMPTOMS AND OVERACTIVE BLADDER: A PROSPECTIVE, RANDOMIZED CONTROLLED TRIAL
    Jung, W.
    Kim, T. H.
    Jeong, J.
    Seo, S., I
    Jeon, S. S.
    Lee, H. M.
    Choi, H. Y.
    Lee, K.
    NEUROUROLOGY AND URODYNAMICS, 2014, 33 (06) : 959 - 960
  • [2] SINGLE DOSE AND STEADY-STATE PHARMACOKINETICS OF 4MG AND 8MG ORAL SALBUTAMOL CONTROLLED-RELEASE IN PATIENTS WITH BRONCHIAL-ASTHMA
    LIPWORTH, BJ
    CLARK, RA
    DHILLON, DP
    CHARTER, MK
    PALMER, JBD
    MCDEVITT, DG
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 37 (01) : 49 - 52
  • [3] Efficacy and safety of Doxazosin GITS in hypertensive renal transplant patients:: Comparison of 8 and 4 mg
    Oliveras, A
    Hurtado, S
    Vázquez, S
    Puig, JM
    Lloveras, J
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (05) : 1732 - 1735
  • [4] SAFETY AND EFFICACY OF 8MG ONCE-DAILY VERSUS 4MG TWICE-DAILY SILODOSIN WITH LOWER URINARY TRACT SYMPTOMS SUGGESTIVE OF BPH; 12-WEEK, DOUBLE-BLIND, RANDOMIZED, COMPARISON, MULTI-CENTER STUDY
    Song, Miho
    Chun, Jiyoun
    Han, Ji-Yeon
    Park, Won Hee
    Paick, Jae-Seung
    Lee, Kyu-Sung
    Choo, Myung-Soo
    Kim, Joon Chul
    Choi, Jong Bo
    NEUROUROLOGY AND URODYNAMICS, 2013, 32 (02) : 161 - 161
  • [5] A Multicenter, Prospective, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4mg Compared with Placebo in Type 2 Diabetes Mellitus Patients Having Hypertriglyceridemia Not Controlled with Atorvastatin Therapy (PRESS VI)
    Jani, Rajendrakumar H.
    Pai, Vikas
    Jha, Pramod
    Jariwala, Gunjan
    Mukhopadhyay, Satinath
    Bhansali, Anil
    Joshi, Shashank
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 (02) : 63 - 71
  • [6] Comparative efficacy and safety profile of 4 vs 8 mg of silodosin once daily usage in patients with benign prostatic hyperplasia-related lower urinary tract symptoms divided into subgroups according to International Prostate Symptom Score severity
    Gul, Abdullah
    Coban, Soner
    Turkoglu, Ali Riza
    Guzelsoy, Muhammet
    Ozturk, Murat
    Kankilic, Nazim Abdulkadir
    PROSTATE INTERNATIONAL, 2020, 8 (04) : 152 - 157
  • [7] EFFICACY AND SAFETY OF INCREASING LOVAZA TO 6-8-12-16 G/D IN PATIENTS WITH TRIGLYCERIDE 9300MG/DL DESPITE INITIAL MAXIMAL THERAPY WITH DIET-FIBRIC ACID-LOVAZA 4G/DAY: A 9 MONTH PROSPECTIVE STUDY
    Khan, A. A.
    Raj, P.
    Umar, M.
    Knoop, L. R.
    Ali, S. S.
    Khan, N.
    Maddipati, M.
    Wang, P.
    Glueck, C. J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2010, 58 (04) : 647 - 647